VCAN and diabetic kidney disease: In previous studies of CKD, versican has been discovered as a predictor of disease progression, but there is no study focusing on the influence of versican on DKD tubulointerstitium (Rudnicki et al., 2012; Han et al., 2019; Taylor et al., 2020).